32 related articles for article (PubMed ID: 20287992)
1. Baseline eosinophil level may be a predictive indicator for the effectiveness of dupilumab in patients with prurigo nodularis: A single-center, real-world prospective study.
Yi X; Cao Q; Peng C; Jia Q; Li J
J Am Acad Dermatol; 2024 May; 90(5):1076-1078. PubMed ID: 38296194
[No Abstract] [Full Text] [Related]
2. Clinical and Temporal Characteristics of Malignancy-Associated Prurigo Nodularis: A Systematic Review.
Green M; Williams L; Kuraitis D
Skinmed; 2024; 22(1):74-78. PubMed ID: 38494622
[No Abstract] [Full Text] [Related]
3. Prurigo nodularis: A "Cinderella" disease with significant burden and a bright future.
Yosipovitch G
J Eur Acad Dermatol Venereol; 2024 May; 38(5):790-791. PubMed ID: 38661023
[No Abstract] [Full Text] [Related]
4. Racial and geographic disparities in global prurigo nodularis clinical trials.
Dagenet CB; Saadi C; Phillips MA; Price KN; Tong L; Hsiao JL; Shi VY
Int J Dermatol; 2024 Jun; ():. PubMed ID: 38845130
[No Abstract] [Full Text] [Related]
5. Prevalence of prurigo nodularis in Sweden.
Antelmi A; Metsini A; Regnell SE; Carlberg M; Svensson Å; von Kobyletzki L
J Eur Acad Dermatol Venereol; 2024 Mar; ():. PubMed ID: 38553871
[No Abstract] [Full Text] [Related]
6. Nemolizumab - a new key player in the treatment of prurigo nodularis.
Reich A
Br J Dermatol; 2024 May; ():. PubMed ID: 38703061
[No Abstract] [Full Text] [Related]
7. Prurigo nodularis: the difference between knowing the path and walking the path.
Carrascosa JM; Munera M
Br J Dermatol; 2024 Jul; ():. PubMed ID: 38959437
[No Abstract] [Full Text] [Related]
8. Prurigo Nodularis: Review and Emerging Treatments.
Leis M; Fleming P; Lynde CW
Skin Therapy Lett; 2021 May; 26(3):5-8. PubMed ID: 34077168
[TBL] [Abstract][Full Text] [Related]
9. Prurigo nodularis and lichen simplex chronicus.
Lotti T; Buggiani G; Prignano F
Dermatol Ther; 2008; 21(1):42-6. PubMed ID: 18318884
[TBL] [Abstract][Full Text] [Related]
10. Prurigo nodularis.
WALZER A
Arch Derm Syphilol; 1947 Mar; 55(3):423. PubMed ID: 20287992
[No Abstract] [Full Text] [Related]
11. Calcitonin gene-related peptide immunoreactivity in prurigo nodularis: a comparative study with neurodermatitis circumscripta.
Vaalasti A; Suomalainen H; Rechardt L
Br J Dermatol; 1989 May; 120(5):619-23. PubMed ID: 2474315
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database Analysis.
Ständer S; Ketz M; Kossack N; Akumo D; Pignot M; Gabriel S; Chavda R
Acta Derm Venereol; 2020 Nov; 100(18):adv00309. PubMed ID: 33021323
[TBL] [Abstract][Full Text] [Related]
13. Prurigo nodularis.
ELFORD WP; WEBER FP
Proc R Soc Med; 1950 Nov; 43(11):835-8. PubMed ID: 14797687
[No Abstract] [Full Text] [Related]
14. [Prurigo nodularis with involvement of the palm].
GERTLER W
Dermatol Wochenschr; 1951; 124(50):1237. PubMed ID: 14926406
[No Abstract] [Full Text] [Related]
15. On pityriasis lichenoides chronica and prurigo chronica nodularis.
WALTHER H
Dermatol Wochenschr; 1953; 127(20):475-9. PubMed ID: 13083062
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
